CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL BIOPROSTHESIS
Report
- Report Number
- 2015691-2011-14978
- Event Type
- Injury
- Date Received
- March 8, 2011
- Date of Event
- February 7, 2011
- Report Date
- February 7, 2011
- Manufacturer
- EDWARDS LIFESCIENCES
- Product Code
- DYE
- PMA / PMN Number
- P860057/S042
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NJ, US
- Reporter Occupation
- PHYSICIAN
Narratives
ADDITIONAL MANUFACTURER NARRATIVE: COMPLAINT DATABASE INDICATES NO OTHER REPORTED EVENTS RELATED TO STERILIZATION, ENDOCARDITIS, OR SUSPECTED INFECTION ON ANY DEVICES MANUFACTURED WITHIN THE SAME STERILIZATION LOT OF THE PROVIDED SERIAL NUMBER. EDWARDS LIFESCIENCES MAINTAINS STERILIZATION CONTROLS AND VALIDATION STUDIES WHICH ARE CONDUCTED IN ACCORDANCE WITH ISO STANDARDS AND MEET GLOBAL REGULATIONS ASSURING DEVICE SAFETY. THESE VALIDATION STUDIES DEMONSTRATE HIGH EFFECTIVITY AND RELIABILITY, EXCEEDING STERILIZATION REQUIREMENTS. OVERALL, THE INVESTIGATION REVEALS NOTHING TO INDICATE A QUALITY DEFICIENCY DURING THE MANUFACTURE OF THE DEVICE THAT MAY HAVE CONTRIBUTED TO THIS EVENT.
METHOD: DEVICE NOT RETURNED. ADDITIONAL MANUFACTURER NARRATIVE: THE DEVICE HISTORY RECORD (DHR) REVIEW WAS COMPLETED AND THIS DEVICE PASSED ALL MANUFACTURING AND STERILIZATION INSPECTIONS WITH NO NONCONFORMANCE. LATE PROSTHETIC VALVE ENDOCARDITIS, OCCURRING MORE THAN 60 DAYS AFTER SURGERY, IS USUALLY CAUSED BY AN INFECTION WHICH OCCURS ELSEWHERE IN THE BODY, AND THEN SEEDS THE VALVE. THE MOST FREQUENT CAUSES ARE DENTAL PROCEDURES, UROLOGICAL INFECTIONS AND INTERVENTIONS, AND INDWELLING CATHETERS. EDWARDS LIFESCIENCES HAS VALIDATED METHODS FOR STERILIZATION OF ALL DEVICES WHICH ENSURES PRODUCT STERILITY.
ON (B)(6) 2011, THE CLINICAL STUDY SITE WROTE "SUBJECT 2109 HAS ENDOCARDITIS AND WILL BE HAVING THE VALVE REMOVED THIS WEEK." ON (B)(6) 2011 THE DEVICE WAS EXPLANTED AFTER AN IMPLANT DURATION OF APPROXIMATELY 4 MONTHS. THE OPERATIVE REPORT LISTS "PROSTHETIC AORTIC VALVE ENDOCARDITIS WITH SEVERE PARAVALVULAR AORTIC INSUFFICIENCY AND PRESUMED INFECTION OF PERMANENT BIVENTRICULAR PACEMAKER" AS THE POST-OPERATIVE DIAGNOSIS. ADDITIONAL INFORMATION: SUBJECT HAD PROGRESSIVE SHORTNESS OF BREATH, ORTHOPNEA, PND AND INCREASED ABDOMINAL AND LEG SWELLING SINCE LATE (B)(6) 2010. ECHO PERFORMED ON (B)(6) SHOWED MOD TO SEVERE AORTIC REGURGITATION, SEVERE TRICUSPID REGURGITATION AND MODERATE MITRAL REGURGITATION. TEE SHOWED WIDE OPEN SEVERE AORTIC INSUFFICIENCY LIKELY PARAVALVULAR LEAK AND SEVERE MITRAL REGURGITATION. EXPLANTED DUE TO PERIVALVULAR LEAK, ENDOCARDITIS ORGANISM: STAPH. EPIDERMIDIS. DEVICE HAD NO THROMBUS, VEGETATION, SUTURE INTERFERENCE, CALCIFICATION OR FIBROSIS. HOWEVER THE DEVICE DID SHOW DEHISCENCE AND THERE WAS AORTIC ROOT ABSCESS." PER OPERATIVE REPORT: THE PATIENT IS A (B)(6) YEAR OLD MAN SEVERAL MONTHS STATUS POST MINIMALLY INVASIVE AORTIC VALVE REPLACEMENT. THE PATIENT HAD BEEN DOING WELL FOLLOWING DISCHARGE FOR A FEW MONTHS BUT THEN BEGAN TO DEVELOP SYMPTOMS OF HEART FAILURE. DIAGNOSTIC EVALUATION SHOWED SEVERE PARAVALVULAR AORTIC INSUFFICIENCY. HE WAS ADMITTED TO THE HOSPITAL, AND BACTERIAL ENDOCARDITIS WAS DIAGNOSED WITH STAPH SPECIES GROWN FROM ALL CULTURES. THE PATIENT WAS STARTED ON ANTIBIOTICS AND TREATED FOR HEART FAILURE. HE WAS ULTIMATELY STABILIZED AND WAS REFERRED FOR SURGERY. BECAUSE OF THE ENDOCARDITIS AND RECENT PACEMAKER SYSTEM, EXPLANTATION OF HIS PERMANENT PACEMAKER WAS REQUESTED. THE PATIENT WAS PLACED ON CARDIOPULMONARY BYPASS. UPON INSPECTION OF THE PROSTHETIC AORTIC VALVE, IT APPEARED TO BE DEHISCED ALONG THE NON-CORONARY AREA AND THE LEFT CORONARY AREA. MINIMAL TRACTION WAS PLACED ON THE VALVE, AND THE REMAINING SUTURES WERE CUT. THE VALVE WAS DELIVERED, AND CULTURES WERE OBTAINED FROM THE AORTIC ROOT. EXTENSIVE AND AGGRESSIVE DEBRIDEMENT OF THE AORTIC ROOT WAS NOW CONDUCTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | CARPENTIER-EDWARDS PERIMOUNT MAGNA EASE PERICARDIAL BIOPROSTHESIS | REPLACEMENT HEART VALVE | DYE | EDWARDS LIFESCIENCES | 3300TFX | R-10E1289 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 69 YR | Hospitalization| R |